September 2023 in “Journal of the American Academy of Dermatology” Recognizing IPPP is crucial to prevent misdiagnosis and unnecessary treatments.
September 2023 in “Journal of the American Academy of Dermatology” This study found a high concordance between subject-reported and clinician-reported Fitzpatrick Skin Phototypes, but 14% of subjects misjudged their skin type, often overestimating it.
This study evaluated genetic differences in hair loss patients from Romania and Brazil, finding that specific gene variations were more common in Brazilian patients. The researchers suggest certain drugs may be more effective based on these genetic markers, but most genes showed no population differences.
In this retrospective analysis, researchers evaluated 54 patients undergoing soft tissue reconstruction for scalp and forehead defects and reported excellent aesthetic outcomes with local flaps for defects up to 50 cm², while larger defects typically required additional skin grafting.
June 2023 in “Journal of General Procedural Dermatology and Venereology Indonesia” This study explores the risk factors for androgenetic alopecia in women residing in Pasar Ambacang Sub-district, Padang City, emphasizing its potential impact on their quality of life and psychological well-being.
Deuruxolitinib effectively promotes hair regrowth in alopecia areata.
May 2023 in “Bali Medical Journal” This study found a very strong positive correlation between sebum levels and the severity of androgenetic alopecia in men.
May 2023 in “International Journal of Trichology” In this study, PRP therapy did not show significant effectiveness in treating androgenetic alopecia in patients over a 6-month period, with 45% of participants reporting no improvement in hair growth, although adverse effects were minimal and non-serious.
April 2023 in “Journal of Investigative Dermatology” This study found that multidisciplinary group medical visits for patients with alopecia areata improved patient satisfaction, knowledge, and access to care at Lahey Hospital and Medical Center.
April 2023 in “International journal of science and research” In this study, PRP treatment improved hair loss in 40 female patients with female pattern alopecia, with most progressing to better grades of hair coverage after 6 months, while only minor pain was occasionally reported as an adverse effect.
February 2023 in “Journal of Drugs in Dermatology” In this literature review, researchers found evidence that topical melatonin may improve scalp hair growth, density, and thickness in patients with androgenetic alopecia, especially in men.
January 2023 in “Our Dermatology Online” An old recipe called "Champigny Saumure" might help treat a rare scalp condition.
January 2023 in “Ankara Üniversitesi tıp fakültesi mecmuası” This study found that the leading reason for dermatology consultations in a pediatric tertiary care hospital was unspecified rash, accounting for 16.1% of cases.
January 2023 in “Laryngoscope” This review found that while platelet-rich plasma shows potential benefits for hair restoration, there is a lack of standardized preparation and treatment protocols, necessitating further rigorous trials.
January 2023 in “Dermatologic Therapy” This study suggests that platelet-rich plasma is a safe and effective treatment for alopecia areata, showing superior treatment response compared to triamcinolone acetonide and placebo, with primarily minor side effects.
January 2023 in “Food and nutrition sciences” This study observed that a significant majority of participants who used the dietary supplement Nutrifii™ Renew reported improvements in various health outcomes, including sleep and energy, compared to a multivitamin/mineral group.
January 2023 in “Faculty of 1000 Research Ltd” This study found a strong interest among aesthetic plastic surgeons in Guangdong, China, for further training courses, with significant differences in training preferences between private and government hospital surgeons.
November 2022 in “Journal of Investigative Dermatology” This study observed that bullous pemphigoid was the most common subepidermal blistering disorder in South Indian patients, with specific histopathological and immunofluorescence characteristics detailed.
November 2022 in “Orphanet Journal of Rare Diseases” This review discusses treatment options for hereditary angioedema and reports no new results; it highlights concerns about androgen side effects and mentions approved alternatives with fewer serious adverse effects.
October 2022 in “BMC genomics” This study investigated adenosine-to-inosine RNA editing in the hair follicle cycle of Tianzhu white yak, identifying numerous editing sites and suggesting their involvement in pathways related to hair growth.
October 2022 in “Dermatology practical & conceptual” This study found that injecting drug users attending an oral substitution therapy center often experience skin lesions, which negatively impact their psychosocial health and quality of life.
August 2022 in “JAAD case reports” This case report describes a 36-year-old woman with hidradenitis suppurativa whose condition progressed to rapidly fatal squamous cell carcinoma, highlighting the potential for aggressive tumor development linked to specific protein markers.
July 2022 in “Revista Ibero-Americana de Humanidades, Ciências e Educação” This study found that most women who recovered from COVID-19 in one Brazilian neighborhood experienced lingering symptoms like fatigue and headache, with few undergoing rehabilitation.
This study provides a detailed analysis of cell subpopulations in a mouse model of wound-induced hair follicle regeneration, revealing specific cellular dynamics and heterogeneity that may influence hair follicle neogenesis.
May 2022 in “Journal of the Egyptian Women's Dermatologic Society (Print)” This article discusses the clinical features and treatment options for common types of hair loss in women and reports no new clinical results.
March 2022 in “IP Indian journal of clinical and experimental dermatology” This study found that ferritin and cobalamin levels were better indicators than hemoglobin in assessing chronic nonscarring hair loss in females of reproductive age.
March 2022 in “International Journal of Trichology” This case study reported that prolonged use of the cancer drug Erlotinib in a postmenopausal woman was associated with trichomegaly and hypertrichosis, highlighting the importance of considering medication history in such cases.
February 2022 in “CRC Press eBooks” This chapter reviews various hair disorders, focusing on androgenetic and scarring alopecias, and discusses management strategies, but presents no new research findings.
January 2022 in “Open Access Macedonian Journal of Medical Sciences” This case report discusses a 5-year-old boy with alopecia totalis who initially experienced regrowth after treatment with Prosential, minoxidil 2%, and clobetasol propionate 0.05%, but later relapsed.
January 2022 in “IAR Journal of Parasitology & Infectious Disease” This study observed that 30.1% of older adults had nail changes, predominantly affecting the lower limbs, and hair disorders were less common, with alopecia being the only type recorded.